Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Morfa, Miguel Díaz
PETHEMA LAL-2019, NCT04179929: Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults	Recruiting	N/A	300	Europe	Pediatric-type of chemotherapy, allogeneic HSCT	PETHEMA Foundation	Acute Lymphoblastic Leukemia	11/26	02/27
Acuña, Miren
GRACE, NCT05636709: National GMA Post-market Clinical Follow-up Study	Recruiting	N/A	350	Europe	Adacolumn	Adacyte Therapeutics SL	Crohn Disease, Ulcerative Colitis	01/25	12/25
Arribas, Sonia
GRACE, NCT05636709: National GMA Post-market Clinical Follow-up Study	Recruiting	N/A	350	Europe	Adacolumn	Adacyte Therapeutics SL	Crohn Disease, Ulcerative Colitis	01/25	12/25